Thiard News@F4F

@newsen.bsky.social

2 weeks ago

IceCure Medical's New $4 Million Offering Signals Growth for Cryoablation Technology IceCure Medical Ltd. announces a $4 million registered direct offering alongside a concurrent private placement, enhancing its cryoablation technology market.

IceCure Medical's New $4 Million Offering Signals Growth for Cryoablation Technology #Israel #Caesarea #IceCure_Medical #Cryoablation #Nasdaq_ICCM

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

IceCure's Promising 5-Year Study Results for Kidney Cancer Cryoablation Show High Recurrence-Free Rates IceCure Medical has revealed impressive five-year results from its ICESECRET study, highlighting significant recurrence-free rates for kidney cancer treatment, promoting its minimally invasive ProSense® technology.

IceCure's Promising 5-Year Study Results for Kidney Cancer Cryoablation Show High Recurrence-Free Rates #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

IceCure Medical Welcomes Meir Peleg as Chief Financial Officer to Drive Growth IceCure Medical has appointed Meir Peleg as its CFO, bringing years of financial expertise to aid in the company's strategic growth in cryoablation technology.

IceCure Medical Welcomes Meir Peleg as Chief Financial Officer to Drive Growth #Israel #Caesarea #IceCure_Medical #ProSense #Meir_Peleg

Thiard News@F4F

@newsen.bsky.social

1 month ago

IceCure Medical's ProSense® Cryoablation Gains FDA Approval for Breast Cancer Study The FDA has approved IceCure Medical's ProSense® cryoablation system for a post-marketing study in low-risk breast cancer treatment, engaging major U.S. medical institutions.

IceCure Medical's ProSense® Cryoablation Gains FDA Approval for Breast Cancer Study #United_States #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

1 month ago

American Society of Breast Surgeons Endorses Cryoablation for Early-Stage Breast Cancer Treatments The American Society of Breast Surgeons has updated its Resource Guide, recommending cryoablation as a viable option for low-risk early-stage breast cancer patients, improving treatment choices.

American Society of Breast Surgeons Endorses Cryoablation for Early-Stage Breast Cancer Treatments #United_States #None #IceCure_Medical #ProSense_Cryoablation #ASBrS

Thiard News@F4F

@newsen.bsky.social

1 month ago

IceCure Medical's ProSense Cryoablation: A Game-Changer for Breast Fibroadenoma Treatment IceCure Medical's recent study reveals the effectiveness of ProSense® cryoablation for treating breast fibroadenomas, fostering potential shifts in clinical guidelines.

IceCure Medical's ProSense Cryoablation: A Game-Changer for Breast Fibroadenoma Treatment #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

1 month ago

IceCure Medical Marks Milestone in Kidney Cancer Cryoablation Study with 5-Year Follow-Up Outcomes IceCure Medical has completed a significant 5-year follow-up in its ICESECRET kidney cancer cryoablation study. Final analysis is anticipated by Q2 2026.

IceCure Medical Marks Milestone in Kidney Cancer Cryoablation Study with 5-Year Follow-Up Outcomes #Israel #Caesarea #IceCure_Medical #ProSense #Kidney_Cancer

Thiard News@F4F

@newsen.bsky.social

1 month ago

IceCure Medical Launches ProSense® at Thomas Hospital in Alabama: A Significant Milestone for Breast Cancer Treatment IceCure Medical's ProSense® system is now available at Thomas Hospital, making it the first facility in Alabama to provide breast cancer cryoablation, enhancing treatment options for patients.

IceCure Medical Launches ProSense® at Thomas Hospital in Alabama: A Significant Milestone for Breast Cancer Treatment #United_States #IceCure_Medical #ProSense® #Fairhope #Thomas_Hospital

Thiard News@F4F

@newsen.bsky.social

2 months ago

Shero Imaging Pioneers Breast Cancer Cryoablation in Missouri with IceCure’s ProSense® Technology Shero Imaging becomes the first clinic in Missouri to offer breast cancer cryoablation using IceCure’s ProSense® technology, enhancing treatment options.

Shero Imaging Pioneers Breast Cancer Cryoablation in Missouri with IceCure’s ProSense® Technology #USA #St._Louis #IceCure_Medical #ProSense® #Shero_Imaging

Thiard News@F4F

@newsen.bsky.social

2 months ago

IceCure Medical Announces CFO Departure After Key Achievements in Nine Years IceCure Medical has announced the departure of CFO Ronen Tsimerman after nearly a decade, highlighting significant milestones achieved during his tenure.

IceCure Medical Announces CFO Departure After Key Achievements in Nine Years #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

2 months ago

IceCure Medical Reports Record Sales of ProSense® and Strengthens Market Position IceCure Medical reports record-breaking 2025 sales of ProSense®, following FDA approval for treating low-risk breast cancer, with strong market demand in the U.S.

IceCure Medical Reports Record Sales of ProSense® and Strengthens Market Position #Israel #Caesarea #IceCure_Medical #ProSense® #Eyal_Shamir

Thiard News@F4F

@newsen.bsky.social

3 months ago

IceCure Medical Anticipates Record Sales in North America Following FDA Clearance of ProSense® Cryoablation System IceCure Medical is set to report record fourth quarter sales in North America, thanks to FDA's approval of the ProSense® system for low-risk breast cancer treatment.

IceCure Medical Anticipates Record Sales in North America Following FDA Clearance of ProSense® Cryoablation System #USA #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

4 months ago

IceCure's ProSense® Cryoablation Gains Traction at RSNA 2025 Annual Meeting with Promising New Studies IceCure Medical's ProSense® Cryoablation was showcased in four independent breast cancer studies at the RSNA 2025 Annual Meeting, emphasizing its effectiveness and growing acceptance in non-surgical treatments.

IceCure's ProSense® Cryoablation Gains Traction at RSNA 2025 Annual Meeting with Promising New Studies #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

4 months ago

IceCure Medical Advances Cryoablation Technology with New Patent in China for Improved Patient Outcomes IceCure Medical has received a Notice of Patent Allowance in China, enhancing their cryoablation systems. This advances patient care significantly.

IceCure Medical Advances Cryoablation Technology with New Patent in China for Improved Patient Outcomes #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

4 months ago

IceCure Medical Faces Nasdaq Minimum Bid Price Notification: Next Steps outlined IceCure Medical Ltd. has announced that it has received a Nasdaq notification regarding minimum bid price non-compliance, sparking a 180-day compliance period.

IceCure Medical Faces Nasdaq Minimum Bid Price Notification: Next Steps outlined #Israel #Caesarea #IceCure_Medical #Nasdaq_Listing #ICCM

Thiard News@F4F

@newsen.bsky.social

5 months ago

IceCure Medical Elevates Shay Levav to COO to Enhance Commercial Expansion IceCure Medical has named Shay Levav as Chief Operating Officer, boosting its leadership team as the company expands following FDA clearance for ProSense®.

IceCure Medical Elevates Shay Levav to COO to Enhance Commercial Expansion #Israel #Caesarea #IceCure_Medical #ProSense #Shay_Levav

Thiard News@F4F

@newsen.bsky.social

5 months ago

IceCure's Innovative Cryoablation System Enhances Lung Cancer Survival Rates Significantly IceCure's Cryoablation System, in combination with SBRT, leads to a remarkable 92% disease-specific survival rate for lung cancer patients, significantly improving outcomes.

IceCure's Innovative Cryoablation System Enhances Lung Cancer Survival Rates Significantly #Israel #Caesarea #IceCure_Medical #Cryoablation #SBRT

Thiard News@F4F

@newsen.bsky.social

5 months ago

IceCure's Innovative ProSense® Cryoablation System Promotes Advanced Breast Cancer Care Discover how IceCure Medical's ProSense® system showcased innovative cryoablation technology at the TME Fall Summit, aiming to reshape breast cancer treatment.

IceCure's Innovative ProSense® Cryoablation System Promotes Advanced Breast Cancer Care #United_States #New_Orleans #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

6 months ago

IceCure Medical Announced Participation in 2025 Maxim Growth Summit in NYC IceCure Medical will showcase its innovative cryoablation technology at the 2025 Maxim Growth Summit, marking a significant milestone for breast cancer treatment.

IceCure Medical Announced Participation in 2025 Maxim Growth Summit in NYC #United_States #New_York #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

6 months ago

IceCure Secures Approval for Innovative XSense™ Cryoablation System in Israel IceCure Medical has obtained regulatory approval in Israel for the XSense™ Cryoablation System, enhancing treatment options for breast cancer and other conditions.

IceCure Secures Approval for Innovative XSense™ Cryoablation System in Israel #Israel #Caesarea #IceCure_Medical #Breast_Cancer #XSense_Cryoablation

Thiard News@F4F

@newsen.bsky.social

7 months ago

New Research Highlights IceCure's ProSense in Breast Cancer Treatments with Promising Patient Satisfaction Rates Recent studies reveal that IceCure's ProSense cryoablation technology shows remarkable patient satisfaction in breast cancer treatment, with a stunning 95% satisfaction rate.

New Research Highlights IceCure's ProSense in Breast Cancer Treatments with Promising Patient Satisfaction Rates #Israel #Caesarea #IceCure_Medical #ProSense_Cryoablation #THERMAC_Trial

Thiard News@F4F

@newsen.bsky.social

7 months ago

IceCure's ProSense® Shows High Effectiveness in Alleviating Endometriosis Pain IceCure Medical Ltd. announces that its ProSense® cryoablation significantly reduces abdominal wall endometriosis pain, providing notable clinical benefits.

IceCure's ProSense® Shows High Effectiveness in Alleviating Endometriosis Pain #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense®

Thiard News@F4F

@newsen.bsky.social

7 months ago

IceCure Medical Reports Promising Financial and Operational Progress in First Half of 2025 IceCure Medical announces its financial results for H1 2025, highlighting advancements in cryoablation technology and significant FDA interactions.

IceCure Medical Reports Promising Financial and Operational Progress in First Half of 2025 #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense®

Thiard News@F4F

@newsen.bsky.social

8 months ago

Innovative Cryoablation Therapy Promises High Success Rates for Breast Cancer Treatment in Japan Recent studies reveal that IceCure's ProSense® can significantly reduce breast cancer recurrence rates. The findings were shared at a prominent conference in Japan.

Innovative Cryoablation Therapy Promises High Success Rates for Breast Cancer Treatment in Japan #Japan #Tokyo #IceCure_Medical #Breast_Cancer #ProSense

Thiard News@F4F

@newsen.bsky.social

8 months ago

IceCure Medical Urges Shareholders to Act Before Rights Offering Deadline IceCure Medical reminds shareholders of the rapidly approaching deadline for its rights offering. Don't miss your chance to invest in innovative cryoablation technology.

IceCure Medical Urges Shareholders to Act Before Rights Offering Deadline #Israel #Caesarea #IceCure_Medical #Cryoablation #Rights_Offering

Thiard News@F4F

@newsen.bsky.social

9 months ago

IceCure Medical Launches Rights Offering for Growth and Innovation in Cryoablation Technology IceCure Medical has initiated a rights offering allowing existing shareholders to purchase shares and warrants, aiming to raise $10 million to further its innovative cryoablation technology.

IceCure Medical Launches Rights Offering for Growth and Innovation in Cryoablation Technology #Israel #Caesarea #IceCure_Medical #Cryoablation #Rights_Offering

Thiard News@F4F

@newsen.bsky.social

9 months ago

IceCure Medical Reports Preliminary Financial Results for Q2 2025 Amid Delivery Delays IceCure Medical Ltd. announces preliminary financial results for Q2 2025, reporting $525,000 in product sales amidst temporary shipment delays.

IceCure Medical Reports Preliminary Financial Results for Q2 2025 Amid Delivery Delays #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense

Thiard News@F4F

@newsen.bsky.social

9 months ago

IceCure Medical Sets Record Date for Major Rights Offering Up to $10 Million IceCure Medical Ltd. announces a landmark rights offering, enabling shareholders to invest in the future of cryoablation technology with a potential raise of up to $10 million.

IceCure Medical Sets Record Date for Major Rights Offering Up to $10 Million #Israel #Caesarea #IceCure_Medical #Cryoablation #Rights_Offering

Thiard News@F4F

@newsen.bsky.social

10 months ago

IceCure Medical's Latest Patent Will Enhance Cryoablation Efficiency for Patients IceCure Medical announces a new patent for cryogen flow control, boosting its innovative cryoablation technology to enhance patient treatment options.

IceCure Medical's Latest Patent Will Enhance Cryoablation Efficiency for Patients #Israel #Caesarea #IceCure_Medical #ProSense_Cryoablation #Cryogen_Flow_Control

Thiard News@F4F

@newsen.bsky.social

10 months ago

IceCure Medical’s Q1 2025 Financial Performance: Progress and Opportunities IceCure Medical Ltd. has reported its financial results for Q1 2025, showcasing advances in cryoablation technology and notable growth in North America and overseas.

IceCure Medical’s Q1 2025 Financial Performance: Progress and Opportunities #Israel #Caesarea #IceCure_Medical #Cryoablation #ProSense